Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 23;16(3):e0248104. doi: 10.1371/journal.pone.0248104

Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi

John Robert Matyas 1,*, Claudia Klein 2,¤, Dragana Ponjevic 1, Neil A Duncan 3, Gregory N Kawchuk 4
Editor: Rajakumar Anbazhagan5
PMCID: PMC7987143  PMID: 33755684

Abstract

Back pain and intervertebral disc degeneration are prevalent, costly, and widely treated by manual therapies, yet the underlying causes of these diseases are indeterminate as are the scientific bases for such treatments. The present studies characterize the effects of repetitive in vivo manual loads on porcine intervertebral disc cell metabolism using RNA deep sequencing. A single session of repetitive manual loading applied to the lumbar spine induced both up- and down-regulation of a variety of genes transcribed by cells in the ventral annuli fibrosi. The effect of manual therapy at the level of loading was greater than at a level distant to the applied load. Gene ontology and molecular pathway analyses categorized biological, molecular, and cellular functions influenced by repetitive manual loading, with over-representation of membrane, transmembrane, and pericellular activities. Weighted Gene Co-expression Network Analysis discerned enrichment in genes in pathways of inflammation and skeletogenesis. The present studies support previous findings of intervertebral disc cell mechanotransduction, and are the first to report comprehensively on the repertoire of gene targets influenced by mechanical loads associated with manual therapy interventions. The present study defines the cellular response of repeated, low-amplitude loads on normal healthy annuli fibrosi and lays the foundation for future work defining how healthy and diseased intervertebral discs respond to single or low-frequency manual loads typical of those applied clinically.

Introduction

Persistent low back pain is a global problem responsible for more years-lived-with-disability than any other condition [1, 2]. Hence, the health, societal, and economic burdens associated with persistent low back pain approximate those of cardiovascular disease, cancer, mental illness, and autoimmune diseases [3]. However, the causes of persistent back pain are poorly understood and, as a consequence, many different treatments are recommended to patients, including surgical and conservative interventions. Given that many common treatments also have the potential to produce significant harm (e.g., chronic NSAIDS, opioids, surgery), conservative interventions for back pain are worthy of full consideration. Delivered by various health professionals, including physical therapists, athletic therapists, osteopaths, and most commonly chiropractors, spinal manipulative therapy is a conservative intervention that is recommended by several guidelines for people with chronic back pain [46]. The procedure entails rapidly applying manual force to the external surface of the back with the intention of improving spinal musculoskeletal function and reducing pain. Previous experimental studies on pig spines, using carefully calibrated robotic movements to reproduce clinical manual therapy, indicate that when manual force is applied to the spine, the intervertebral discs (IVD) receive the largest fraction of the applied load of all spinal tissues [7], and manual loading applied to the dorsal spine is expected to induce maximal loading in the ventral annuli fibrosi. Nevertheless, it remains unclear how applying forces for such a short duration might trigger either immediate or sustained biological responses in IVD tissues. Qualifying and quantifying biological responses of any kind after spinal manual therapy is an important first step in understanding how manual force might transduce a local therapeutic effect in the spine.

It is noteworthy that, in a number of clinical and pre-clinical studies, external mechanical loads reportedly transduce biological changes in the IVD. For example, clinical surgery designed to correct excessive spinal curvature (scoliosis) imparts sustained, large-magnitude forces to the IVD that induces tissue remodeling [8], which has been confirmed experimentally in animals [9]. Similarly, experimental implantation of special loading devices that apply static and dynamic, compressive or distractive, forces across spinal segments of rats and mice have been shown to induce demonstrable biological changes in the IVDs [912]. Moreover, mechanical loading of IVDs in organ culture induces alterations in matrix metabolism [1315] as it does in IVD cells isolated, cultured, and loaded in vitro [16]. In all these experiments, load elicits biochemical, biophysical, or biological responses in the IVD that may, in turn, influence other systems. For example, it has been reported recently that spinal manipulation reduces spinal stiffness, changes disc diffusion, alters muscle function [6] and may possibly induce changes in neurophysiology (e.g., see review [17]). In these studies the possible role of IVD nerve endings is unknown, yet the presence of nerves in the outer annulus of normal [18] and degenerating discs [19] plausibly implicates the annuli fibrosi in spinal nociception.

Whereas a number of physiological processes may alter the biochemistry and mechanical function of the extracellular matrix in the long-term (e.g., collagen cross-linking or glycation), the primary short-term biological response of the IVD to mechanical loading is most likely to occur in the cells. Mechanotransduction, the transduction of an external mechanical stimulus into cellular activity, can be initiated by transcription of nucleic acids encoding for downstream translation of proteins that can serve as structural (e.g., collagens and proteoglycans) or regulatory (e.g., enzymes) roles in extracellular matrix biosynthesis and assembly, as cytokines involved in immune regulation and inflammation, as stimuli for membrane depolarization, and as promoters of gene activation or inhibition. Indeed, a remarkable mechanobiology study reports responses by intervertebral disc cells to such IVD loads detectable from even a single (1.5 hr) loading event [20], including both upstream (i.e., altered gene expression) as well as downstream effects (i.e., altered tissue concentrations of extracellular matrix proteoglycan and collagen). Notably, these authors report that mRNA changes in annuli fibrosi persist, whereas those in nucleus pulposus were transient [20]. The present experiments seek to explore the sensitivity of ventral annuli fibrosi cells—the cells responsible for maintaining the structural integrity of the disc—in responding to loads typical of those in clinical practice when applied repeatedly by in vivo spinal manipulation of a porcine model using a discovery-based, broad-spectrum gene expression analysis.

Before it is possible to credibly interpret a "clinical dose” of manual therapy (i.e., the episodic application of short-term loads), it is necessary to define positive and negative controls to frame the interpretation of clinical loading paradigms. The present study seeks to identify any gene candidates of manual therapy-induced mechanotransduction by evaluating differences between the gene expression of IVD cells in positive and negative controls. In this initial study, a porcine model is used to define any changes in gene expression, as indices of cell responsiveness, in healthy normal annuli fibrosi of positive controls (treated with multiple applications of manual therapy over several hours) and sham-treated (non-loaded) negative controls. These initial proof-of-principle studies intend to serve as a foundation for future gene expression analyses of normal and diseased annuli fibrosi loaded using clinical doses of manual therapy of the spine.

Results

The mean (±SD) yield of total RNA was 0.089 ± 0.035 (μg/mg wet weight) for the central ventral wedge of the L3-4 annuli fibrosi. There was no significant difference in RNA yield among intervertebral discs between Hyperloaded and Control specimens (p = 0.49).

RNA deep sequencing

After quality control (see Methods), 17.7 million raw reads per sample were aligned on average, revealing 13,402 unique expressed transcripts; of these, 11,370 were annotated sufficiently for DAVID analysis. Following filtering for transcripts, unsupervised hierarchical cluster analysis (JMP Genomics) detected two distinct groups that corresponded to Non-loaded Controls and Hyperloaded groups as evidenced clearly on the heatmap of raw data, which is presented with a sorted dendrogram of transcripts of similar expression profiles (Fig 1). Using a cutoff of p<0.01, annuli fibrosi tissues treated with Hyperloading, compared to Non-loaded Controls, were calculated to have 348 mRNAs significantly up-regulated, 430 mRNAs significantly down-regulated, with 10590 mRNAs identified as “background,” (i.e., transcribed mRNAs with levels p≥0.01). A Principal Component Plot reveals close clustering of Hyperloaded samples implying that any effects of loading duration or frequency are indistinguishable (Fig 2). Table 1 lists, by fold-change in transcript expression, an assortment of 20 differentially expressed transcripts selected by magnitude of change and relevance to IVD pathobiology. The full lists of up- and down-regulated genes are provided online as S1 and S2 Tables.

Fig 1. Heat map of up- and down-regulated transcripts mapped with a dendrogram (red = up-regulated [n = 348]; blue = down-regulated [n = 430]; grey = unchanged [n = 10590]).

Fig 1

The changes in gene expression self-segregated to form distinct quadrants for Non-loaded and Hyperloaded groups.

Fig 2. Principal component analysis (PCA) depicts some variation amongst Non-loaded controls (blue) possibly related to animal age or body mass, yet reveals a noteworthy and distinct segregation of Non-loaded controls from Hyperloaded (red) samples.

Fig 2

Close grouping of Hyperloaded samples infers negligible effects of loading duration and frequency.

Table 1. Twenty selected transcripts with differential expression possibly relevant to IVD pathobiology.

Gene Gene description Fold-Change* p-Value Function (https://www-ncbi-nlm-nih-gov/gene)
CCL8 chemokine ligand 8 49.46 0.0026 Immunoregulatory/Inflammatory
CCL2 C-C motif chemokine 2 26.34 0.0018 Immunoregulatory/Inflammatory
PTPRO protein tyrosine phosphatase, receptor type O 16.96 0.0035 Polarized cell membrane…
CCL24 C-C motif chemokine ligand 24 14.42 0.0045 Immunoregulatory/Inflammatory
TNMD tenomodulin 12.91 0.0073 Angiogenesis inhibitor
ADAMTS4 ADAM metallopeptidase with thrombospondin type 1 motif 4 10.64 0.0115 Aggrecanase
CCL4 C-C motif chemokine 4 8.49 0.0002 Immunoregulatory/Inflammatory
SRGN serglycin 6.15 0.0025 Hematopoietic secreted proteoglycan/apoptosis
IGF1 insulin like growth factor 1 5.11 0.0110 Growth and development
ADAMTS1-201 A disintegrin and metalloproteinase with THBS motifs 1 precursor 4.85 0.0124 Inflammation and angiogenesis inhibitor
GALR3 galanin receptor 3 -3.85 0.0007 Receptor for galanin involved in cognition and pain
ACAN aggrecan -5.26 0.0088 Large aggregating proteoglycan of cartilage
COL11A2 collagen type XI alpha 2 chain -5.56 0.0064 Structural co-polymer with Col2 in cartilage
KCNA1 potassium voltage-gated channel subfamily A member 1 -10.00 0.0014 Voltage-gated potassium channel
FBXO2 F-box protein 2 -10.00 0.0034 Phosphorylation-dependent ubiquitination
Slc12a2 solute carrier family 6 member 12 -11.11 0.0039 Ion balance; cell volume regulation
TPD52L1 tumor protein D52-like 1 -12.50 0.0087 Cell proliferation, calcium signalling, apoptosis
GAL3ST1 galactose-3-O-sulfotransferase 3 -14.29 0.0000 Membrane glycolipid sulfation/myelin
EPS8L2 EPS8 like 2 -14.29 0.0069 Growth factor driven actin re-organization
CILP cartilage intermediate layer protein -14.29 0.0051 IGF-1 antagonist

* Fold-change positive = up-regulated; negative = down-regulated in Hyperloaded versus Non-loaded Controls.

RT-qPCR analysis of select RNA sequencing targets

RT-qPCR results are listed as fold-change in mRNA copy number in Non-loaded Control and Hyperloaded samples and are listed in comparison to RNA sequencing fold-change (Table 2). Note the relatively diminished response to Hyperloading in the L1-2 versus L3-4 discs.

Table 2. Normalized fold-change in Hyperloaded discs of select RT-PCR targets.

Group (Normalized to Control = 1) CCL8 CCL2 AQP9 SRGN CILP COL11A FBLN7
Control (n = 6) 1.00 1.00 1.00 1.00 1.00 1.00 1.00
L3,4 Hyperloaded (n = 4) 8.12 4.09 4.24 4.23 0.78 1.33 0.75
L1,2 Hyperloaded (n = 3)* 2.01 2.20 0.96 1.56 0.55 1.25 0.68
RNAseq Fold-Change (L3,4)** 40.06 26.74 3.18 5.45 0.06 0.36 0.46

*Paired sample t-test for seven RT-PCR targets reveals higher treatment effect in ventral annuli samples from L3,4 (directly under loading site) compared to L1,2 (two segments proximal to loading site) (n = 3) p = 0.043

**Correlation coefficient between fold-change of RT-PCR and RNAseq for seven targets in L3,4 ventral annuli (n = 10) R2 = 0.75

Functional analyses of RNAseq transcripts

DAVID Functional Annotation analysis enumerated transcript count and the percentage of differentially expressed transcripts, of which the top 20 (of 237) are listed in Table 3 along with their calculated Enrichment scores.

Table 3. DAVID: Top 20 clusters of differentially expressed RNA transcripts.

Annotation Cluster Enrichment Score Cellular Functions
Annotation Cluster 1 5.56 Membrane/transmembrane
Annotation Cluster 2 5.35 Chemotaxis/cytokine
Annotation Cluster 3 3.87 Immune Chemotaxis
Annotation Cluster 4 2.84 Rhodopsin; G-coupled receptor
Annotation Cluster 5 1.83 Leucine-rich repeat
Annotation Cluster 6 1.81 Toll-Like Receptor
Annotation Cluster 7 1.61 Collagen/complement
Annotation Cluster 8 1.30 Metalloproteinase/peptidases
Annotation Cluster 9 1.28 Sushi
Annotation Cluster 10 1.14 G-protein signalling
Annotation Cluster 11 1.06 Transplantation antigens
Annotation Cluster 12 0.99 FERM
Annotation Cluster 13 0.89 Protein kinase inhibition
Annotation Cluster 14 0.82 Protein tyrosine phosphatase
Annotation Cluster 15 0.77 Rho GTPase
Annotation Cluster 16 0.60 Transmembrane
Annotation Cluster 17 0.53 Zinc-finger
Annotation Cluster 18 0.53 Cardiomyopathy
Annotation Cluster 19 0.25 Protein kinase
Annotation Cluster 20 0.10 SH3

PANTHER Functional Analyses plot the percentage of listed background, up-, and down-Regulated genes for various Biological Processes, Molecular Functions, and Cellular Components (Fig 3) using Fisher’s Exact test with the FDR multiple-test correction (n = 348 up-regulated; n = 430 down-regulated, and n = 10590 unchanged genes). The numbers of up-regulated and down-regulated genes were highly correlated for each of these analyses (>0.95) and both were highly correlated (>0.92) to the number of background genes (i.e., the number of transcribed genes in each category). Compared to background expression, the relative over- and under-representation of differentially expressed transcripts in Gene Ontogeny (GO) classes of various biological and cellular processes is given in Table 4.

Fig 3. PANTHER GO-Slim results for up-regulated and down-regulated genes analyses for functional networks of biological processes, molecular function, and cellular component.

Fig 3

Note the relative over-representation of regulatory genes (membrane, catalysis, response, regulation) compared to structural genes (extracellular matrix, structural molecule, adhesion) immediately after Hyperloading.

Table 4. Over- and under-representation of PANTHER Gene Ontology (GO) activities compared to background.

Gene Ontology Activity GO number Representation compared to Background
GO Biological Process
RNA metabolic GO:0016070 Under-
Nucleobase-containing Compound Metabolic GO:0006139 Under-
Primary Metabolic GO:0044238 Under-
Nervous System Development GO:0007399 Over-
Single-multicellular Organism GO:0044707 Over-
System Development GO:0048731 Over-
GO Molecular Function NA NA
GO Cellular Component
Cell part GO:0044464 Under-
Cytoplasm GO:0005737 Under-
Intracellular GO:0005622 Under-
Organelle GO:0043226 Under-
Ribonucleoprotein Complex GO:0030529 Under-
Extracellular Region GO:0005576 Over-
Plasma Membrane GO:0005886 Over-

WGCNA (Weighted Gene Co-expression Network Analysis) of differentially expressed transcripts and clinical traits Treatment, Sex, and Body Mass, revealed two major modules of gene networks (blue [240 genes] and turquoise [280 genes] mapped with dendrogram—Fig 4) that strongly associated with the trait Treatment (Non-loading, Hyperloading—Fig 5). Based on calculated enrichments for Gene Ontology, the top 10 ranked transcripts for each module are listed in Table 5. The blue module is enriched with genes that participate principally in inflammatory processes; the turquoise module is enriched with genes that participate principally in skeletogenesis.

Fig 4. Cluster dendrogram with dissimilarity based on topological overlap, together with assigned module colors (in this case blue and turquoise) calculated by WGCNA.

Fig 4

Fig 5. Module-trait associations with each row corresponding to a module eigengene, each column to a trait.

Fig 5

Each cell contains the corresponding correlation and p-value.

Table 5. WGCNA module enrichment interfaced with Gene Ontology.

Module Rank Enrichment P (Fisher Exact) Bonferoni P Genes in Term Term ID GOntology Term Term Name
blue 1 3.93E-09 7.20E-05 40 GO:0019221 Biological Process cytokine-mediated signaling pathway
blue 2 7.66E-08 1.41E-03 47 GO:0071345 Biological Process cellular response to cytokine stimulus
blue 3 7.81E-08 1.43E-03 54 GO:0045321 Biological Process leukocyte activation
blue 4 9.35E-08 1.72E-03 64 GO:0006955 Biological Process immune response
blue 5 1.08E-07 1.98E-03 60 GO:0001775 Biological Process cell activation
blue 6 9.84E-07 1.81E-02 40 GO:0006954 Biological Process inflammatory response
blue 7 1.02E-06 1.86E-02 47 GO:0034097 Biological Process response to cytokine
blue 8 1.12E-06 2.06E-02 83 GO:0002376 Biological Process immune system process
blue 9 1.19E-06 2.18E-02 63 GO:0031982 Cell Component vesicle
blue 10 2.73E-06 5.02E-02 53 GO:0002682 Biological Process regulation of immune system process
turquoise 1 9.39E-04 1.00E+00 11 GO:0048706 Biological Process embryonic skeletal system development
turquoise 2 1.78E-03 1.00E+00 10 GO:0045165 Biological Process cell fate commitment
turquoise 3 3.07E-03 1.00E+00 19 GO:0009100 Biological Process glycoprotein metabolic process
turquoise 4 3.39E-03 1.00E+00 9 GO:0002062 Biological Process chondrocyte differentiation
turquoise 5 4.27E-03 1.00E+00 14 GO:0048705 Biological Process skeletal system morphogenesis
turquoise 6 4.27E-03 1.00E+00 14 GO:0005815 Cell Component microtubule organizing center
turquoise 7 5.32E-03 1.00E+00 27 GO:1901135 Biological Process carbohydrate derivative metabolic process
turquoise 8 6.41E-03 1.00E+00 8 GO:0048704 Biological Process embryonic skeletal system morphogenesis
turquoise 9 7.19E-03 1.00E+00 13 GO:0048839 Biological Process inner ear development
turquoise 10 7.51E-03 1.00E+00 19 GO:0009792 Biological Process embryo development ending in birth or egg hatching

Discussion

Spinal diseases, particularly low back pain, are commonly treated with some form of physical intervention. Even if the underlying mechanisms of these physical interventions are unknown and potentially complex, clinical reports suggest such interventions may influence low back pain in some, though not all, people [21]. Hence, it is unsurprising that extensive clinical and basic research has investigated the influence of physical, i.e., mechanical, loads on the spine pathophysiology. While pathology of the spine, including the intervertebral disc, is commonly documented in patients with a history of back pain, the exact source of back pain remains indeterminate, and it is unclear if manual therapies have any influence on IVD metabolism that might promote repair, preserve health, or diminish pain. This initial study defines changes from baseline gene expression in healthy discs in response to manual loads of magnitudes relevant to clinical treatment.

As with all experiments, these studies have several assumptions and limitations as well as certain advantages. Although the use of skeletally immature, quadrupedal pigs as a model of human IVD biology is an obvious limitation, the size of the pigs in this study enables both precise sampling of IVD tissues and the relevant application of spinal manipulation by an experienced clinician, which makes this model highly advantageous for the purposes of this study. The goal here was to define a positive control for applying compressive manual loading to normal healthy IVD, which leaves future studies to determine, whether or not, any molecular changes might occur after a typical, clinically applied spinal manipulation in healthy and diseased IVDs. Nevertheless, the mRNA changes documented here indicate that IVD cells have a distinct, near-to-short-term (within 4 hours) stimulation of gene transcription in response to applied, repetitive loads, which is in accord with the studies of MacLean et al. [20] and others. It must also be acknowledged that although an equal magnitude of load was applied to all Hyperloaded pigs, two subgroups received different frequencies of load, which would be an insufficient number to discern any graded effect of load. Nevertheless, in the present study, all pigs were entered as individuals into an unsupervised analysis, which statistically determined that they belonged in two distinct groups that corresponded to the binary variable of load, i.e., hyperloaded versus non-loaded individuals. Principal component analysis supports a distinct treatment effect of loading, but no appreciable differences of load history. Lastly, it is noteworthy that the present report pertains only the ventral segment of annuli fibrosi of healthy spines, and based on previously published work in humans [22, 23] and bovines [24], it seems likely that different parts of the intervertebral disc might receive different types and magnitudes of loads and would likely have different cellular responses based on region and health of the disc.

While it is well known that the skeleton responds reliably to repeated loads with biological adaptations (e.g., muscle tone and skeletal density) over long-time scales (weeks-to-months), short-term loads activate cellular metabolism as evidenced by changes in nucleic acid transcription [20], which can be detected and evaluated very precisely by RNA sequencing and RT-qPCR. In the present study, it is noteworthy that the yield of RNA extracted from annuli fibrosi is similar to previous reports of other dense connective tissues such as ligament and tendon [25]. And, of the reverse-transcribed mRNA, 6.8% (778 of 11,368 total transcripts) of ventral annulus transcripts were determined (by unsupervised clustering) to be differentially expressed between Non-loaded Controls and Hyperloaded groups. That transcripts were both up-regulated and down-regulated suggests that a systematic bias is unlikely to account for such differential expression. Moreover, the confirmation by RT-qPCR of transcript changes that generally mimic those of RNA sequencing (Table 2, R2 = 0.75), and a “dose-responsive” effect of loading (L3-4 > L1-2; p< 0.05) supports a genuine biological response to manual loading. The discrete quadrants readily visible on the RNA sequencing heatmap (Fig 1) and the segregation on the PCA plot (Fig 2) highlight the distinct differential expression of RNA transcripts between the Hyperloaded and Non-loaded Control groups, supporting an unbiased and unexpectedly clear treatment effect of a single session of repeated manual loading.

The selection of up-regulated transcripts in Table 1 reveal a preponderance of chemokines and enzymes with catabolic actions on extracellular matrix, while the down-regulated transcripts are notable for diminished expression of the (anabolic) structural (extracellular) matrix components aggrecan and collagen XI. If persistent, such changes infer net overall matrix catabolism, which is opposite to the intended goal of tissue repair and rebuilding, however, initial changes such as these are consistent with tissue inflammation, which necessarily precedes tissue repair. In particular, the strong upregulation of four C-C motif chemokines (CCL2, CCL4, CCL8, CCL24), a collection of specialized secondary mediators of inflammation capable of responding to primary inflammatory mediators such as IL-1beta, implies that annuli cells are preloaded and prepared to respond to mechanical loading with classical inflammation mediators.

The distinct fortification of immune and inflammatory genes identified in the blue module by WGCNA is reinforcing evidence that inflammatory mediators are "first responders" to repetitive mechanical loading, whereas the fortification of genes related to skeletogenesis reinforces evidence for recapitulation of skeletal development as is typical of skeletal and connective tissue responses to injury and inflammation.

Although it is unclear exactly how manual therapy might activate annulus cells, the over-representation of membrane and transmembrane transcripts (Tables 3 and 4) is consistent with various models of cellular mechanotransduction that involve outside-in signaling [26] as well as membrane-associated signaling of immune-recognition and inflammation. In particular, there are noteworthy differentially regulated transcripts encoding for integrins and cytoskeleton (e.g., integrin subunit 4), ion pores (e.g., aquaporin 9), and various membrane receptors (e.g., TLR-2) in response to Hyperloading.

Structural molecules notwithstanding, there are signs of anabolic signaling. For example, there is a noteworthy increase in insulin-like growth factor 1 (IGF-1) and a curious concomitant decrease in the IGF-1-antagonist cartilage intermediate layer protein (CILP). Should such changes result in a net increase in the IGF biosynthesis it could be viewed as a hopeful outcome of manual loading as IGF-1 reportedly has a number of "positive" biological effects, including cell proliferation and matrix synthesis, on intervertebral disc cell metabolism [27]. Even while the overall balance appears to favour catabolism over anabolism, it should be recognized that the targets selectively listed in Table 1 are but a small percentage (20/778 = 2.5%) of the total number of significantly changed transcripts, many of which have unknown functions, hence, it seems fair only to broadly conclude that the cellular response is rich and complex.

MacLean and colleagues used RT-PCT to evaluate a small, select set of mRNA changes in rat (caudal segment) annuli fibrosi (dynamically loaded for 1.5 h) and reported significant and persistent upregulation in the mRNA expression of structural proteins (aggrecan [~ 5-fold], collagen I [~4-fold], and collagen II [~10-fold],) of matrix metalloproteinases (MMP-13 [>10-fold] and MMP-3 [>50-fold]), and the matrix metalloproteinase inhibitor (TIMP-1 [>10-fold]) [20]. Nevertheless, baseline (time zero) mRNA expression of all these mRNAs was not significantly different compared to endogenous non-loaded controls, but became elevated in all mRNAs except MMP-2 when sampled after 8, 24, or 72 hours after loading [20]. Hence, the methods and system of MacLean et al. were relatively insensitive to changes at baseline, yet clearly defined long-lasting changes in gene expression well after the application of mechanical stimulation. In view of MacLean’s findings, the present studies support early initial changes in gene expression that are likely to lead to downstream changes that ultimately could lead to adaptive changes of tissue structure and function.

With respect to discogenic pain, the noteworthy decrease in the expression of galanin receptor 3, which binds the nociception-inhibiting neuropeptide galanin [28, 29] and reportedly has anti-inflammatory activity [30]. These findings provoke speculation that mechanical load might somehow be involved in intervertebral disc neuroinflammation and nociception, which receives some support with the detection of inflammatory pathways in WGCNA analysis.

As with any large dataset, it is difficult to avoid over-interpreting such a long list of differentially regulated transcripts, so it is important to recognize that these studies are a first attempt to define potential targets and pathways that have changed in response IVD loading. Nevertheless, the present studies demonstrate that repetitive manual loading of the living, intact multi-element organ system of the lumbar spine transduces a detectable biological signal, which further reinforces the potential role of mechanobiology in spinal pathobiology, repair, and therapy. Notwithstanding the distinct differential expression of IVD transcripts induced by hyperloading reported here, additional studies are needed to discover whether such changes are robust, repeatable, and lead to functionally significant biological responses to clinical applications of manual therapies.

Materials and methods

The overall experimental design is outlined in Fig 6. Gene expression of annuli fibrosi exposed to in vivo repeated manual loading (as applied in routine practice) or sham manual loading was evaluated using discovery-based RNA deep sequencing, and a selection of several up-regulated and down-regulated gene targets where chosen for validation by RT-qPCR.

Fig 6. Flowsheet of overall experimental design.

Fig 6

Animals

Approval for this experiment was provided by the Animal Care and Use Committee at the University of Alberta (573/07/12). Ten domestic Duroc cross (Large White × Landrace) pigs of mixed sex (6 females; 4 males) were included in these studies. Animals ranged in age from 3–4 mos. old and had body mass of 48 kg ± 4 kg (mean ± SD), a size that facilitated the simulation of manual loading in humans. Animals were cared for according to the guidelines of the Canadian Council of Animal Care under the supervision of a veterinarian. Anesthesia was induced using an initial intramuscular injection of azaperone, glycopyrrolate, and a mixture of ketamine- acepromazine-xlyazine, and was maintained for four hours on a mixture of inhaled isoflurane (~1.5%) and oxygen (1%). At the completion of these acute studies animals were euthanized by intravenous injection of barbiturate (Euthanyl, 150 mg/kg).

Manual spinal therapy

Six animals (four females; two males) were assigned randomly to a “Non-loaded Control” group, and four animals (two females; two males) were assigned to a “Hyperloaded” group. Manual therapy of the spine typical of clinical practice was applied by a trained chiropractor (GK) as described previously [31]. The Non-loaded Controls were anesthetized but did not receive any manual loading. Hyperloaded animals received spinal manipulative therapy applied bilaterally to the L3 vertebra once every 1 or 2 minutes for 4 hours; two pigs received loading once a minute (total manipulations = 240), two pigs were loaded once every two minutes, for four hours (total manipulations = 120). The magnitude of manual spinal loading in pigs was calibrated to 400N, the load measured in the human lumbar spine undergoing clinically simulated manual therapy [32]. Briefly, a thin, flexible 10×10 array of 1 cm2 pressure sensors (sensitivity 0.15%, 120 Hz sampling rate [Pressure Profile Systems, Los Angeles]) was inserted between the hand of the manual therapist (GK) and the animal, which monitored real-time loads throughout the experiment. For these experiments, the repetitive frequencies and total number of applications used for these pigs greatly exceed that delivered clinically with the express purpose of inducing an unequivocal positive loading response, hence, we termed this treatment “hyperloading.”

Tissue sampling and processing

At the completion of these acute studies, animals were euthanized and the lumbar spine was dissected to expose the intervertebral discs. The annuli fibrosi from the central ventral (anterior) sector of the L3-4 intervertebral discs were dissected and removed (Fig 6). Based on the mid-dorsal application of load, this mid-ventral segment of annulus was chosen for analysis as it was expected to experience the maximum resultant load, thus eliciting the maximal mechanobiological response in the cells of the ventral annuli fibrosi. Annulus segments were cut into small pieces (<30 mg), placed into microfuge tubes, weighed on RNAse-free aluminum foil on a microbalance, snap-frozen in liquid nitrogen, placed immediately into RNAse-free containers, and stored at -80°C. Annuli fibrosi was also sampled from the L1-2 IVD based on the assumption that this level experienced less load than the L3-4 disc at the point of loading. Frozen annuli fibrosi tissue samples were weighed and pulverized into a fine powder using a freezer mill (MikroDismembrator; 2600 rpm for 45 seconds) as described previously [33]. Frozen powdered annulus tissue was immersed immediately in 300 μl RLT buffer containing 1% beta mercaptoethanol for extraction and purification of total RNA using the RNeasy Fibrous Tissue Mini Kit (Qiagen Cat No. 74704). Briefly, RLT-tissue lysate was digested with proteinase K at 55°C for 10 min, centrifuged 3 min at 10,000 g, and the supernatant transferred and mixed by pipette with a 0.5 volume of absolute ethanol, which was then pipetted over an RNeasy mini-spun column (Qiagen Cat. No. 74104) and centrifuged for 15 sec at >10,000g at 20–25°C. The column was treated with DNAse I at 22°C for 15 min, washed twice with RW1 Buffer and centrifuged, then eluted with 25 μL for 5 minutes before centrifugation.

Evaluating RNA quality

RNA quality was assessed by microspectrophotometry (NanoDrop ThermoFisher Scientific) and as RNA Integrity Number (RIN) by microelectrophoresis (Agilent RNA 6000 Nano Kit read by 2100 Bioanalyzer [Agilent Technologies, Santa Clara, USA; No. 5067–1511]). All annulus samples had OD260/280 values exceeding 2.0 and RIN values exceeding 8.0, which indicated high purity of RNA used for sequencing and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).

RNA sequence analysis and bioinformatics

Twelve samples from annulus level L3-4 were used for mRNA (cDNA) sequencing (see below): six samples from six Control animals and six samples from four Hyperloaded animals. The two extra Hyperloaded sample replicates from annulus level L3-4 were powdered, isolated, and purified independently to assess repeatability.

Generation of cDNA libraries and sequencing

The TruSeq RNA sample Prep v2 LS protocol (Illumina, San Diego, CA, U.S.A.) was used for preparation of mRNA libraries. Messenger RNA was purified from total RNA samples using poly-T oligo-attached magnetic beads followed by mRNA fragmentation for first- and second-strand cDNA synthesis. The overhangs, which resulted from the fragmentation of double-stranded (ds) cDNA, were repaired to form blunt ends and a single adenosine was added to the 3΄ ends of the blunt fragments to prevent them from ligating to one another during the adapter ligation reaction. Multiple indexing adapters were ligated to the ends of ds cDNA to prepare them for hybridization on a flow cell followed by a PCR amplification step. The libraries were quantified using the qPCR technique and analyzed on a Bioanalyzer 2100 (Agilent Technologies) using a DNA-specific chip. Base calling and demultiplexing of transcriptome sequencing reads were performed using the Consensus Assessment of Sequence and Variance (CASAVA) v 1.6 and Novobarcode software (http://www.novocraft.com/).

Quality control and alignment of reads

Reads were mapped to the porcine genome Sscrofa11.1 (Ensembl, http://www.ensembl.org/) using JMP Genomics 7.1 (SAS, Cary, NC, USA), allowing two mismatches per read. Total counts and transcripts-per-million (TPM) values were generated for all transcripts. Only transcripts detected with at least 10 raw reads in all biological replicates for control and/or treated samples were considered present and included in further analyses.

Data analysis

All data analysis was carried out using TPM values. Quality control, unsupervised clustering, grouped correlation analysis, and Principal Component Analysis (PCA) were performed with JMP Genomics 7.1. Unsupervised cluster analysis is an assumption-free approach, hence, each pig was entered individually (i.e., not as treatment and control groups). One-way analysis of variance ANOVA was used to determine differentially expressed genes. Transcripts displaying a fold-change ≥2 and a p-value of ≤ 0.01 were considered differentially expressed. Unsupervised hierarchical cluster analysis was done using the minimum variance method [34], which minimizes within-cluster variance and assigns mutually exclusive subsets of transcriptome profiles from all samples. These analyses independently segregated groups into Non-loaded Controls and Hyperloaded samples (Fig 1). Subsequent pathway analyses were used using these two distinct groups. Principal component analysis (PCA) was performed to distinguish treatment groups.

PANTHER 9.0 (Protein Analysis Through Evolutionary Relationships) Classification System (http://www.pantherdb.org/) and the Database for Annotation, Visualization and Integrated Discovery (DAVID 6.8; https://david.ncifcrf.gov/) [35] were used to classify differentially expressed genes according to their gene ontology (GO) and to statistically determine over- or under-representation of categories (with Bonferroni correction for multiple testing). All remaining (unchanged) transcripts present in Non-loaded Control and the Hyperloaded samples were entered into the analysis as “background.” Resulting data were supplemented with additional information from Entrez Gene (www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene) and from the literature (http://www.ncbi.nlm.nih.gov/PubMed/). PANTHER was used to identify biological process, molecular function, and cell processes of selected individual genes that were up- and down-regulated in Hyperloaded discs versus Non-loaded Controls.

A systems-level view of genes differentially expressed in Hyperloaded discs was carried out using the WGCNA package in R [36, 37] REF Zhang B and Horvath S (2005); R-project REF). Briefly, pairwise correlations and a power function are calculated to develop a weighted co-expression network of differentially expressed genes, which segregate into discreet clusters termed ‘modules.’ Pig genes in enriched modules were converted to human orthologs before they could be evaluated (Enrichment P determined by Fisher’s Exact test) for functional significance in Gene Ontology (Bioconductor v. 3.12) pathways.

Based on the calculated one-way ANOVA p-value<0.01 for targets with a two-fold change or greater expression (up- and down-regulated targets in Hyperloaded versus Non-loaded Control pigs), a list of potential targets (Table 6) was selected for further validation by RT-qPCR, including: chemokine (C-C motif) ligand 8 (CCL8), chemokine (C-C motif) ligand 2 (CCL2), aquaporin 9 (AQP9), serglycin (SRGN), cartilage intermediate layer protein (CILP), collagen type XI alpha-1 chain (COLL11A1), and fibulin 7 (FBLN7).

Table 6. PCR primer sequences for select RNA transcripts.

Gene NCBI Reference Sequence Forward Primer Reverse Primer
CCL8 NM_001164515 GGTGCTTGCTCAGCCAGATT ACACTGGCTGTTGGTGATTCT
CCL2 NM_214214.1 CTCCAGTCACCTGCTGCTAT TGCTGGTGACTCTTCTGTAGC
AQP9 NM_001112684.1 CAGTCGCGGACATTTTGGAG AAAGACACGGCTGGGTTGAT
SRGN XM_013990411.2 PREDICTED CAAGGTTCTCCTGTGCGGAA AGGGTCAGTCCTTGGAGGTA
CILP NM_001164648.1 CCCTCTACAAGCACGAGAGC GGGTTGCAAGGAGCCTATGA
COL11A1 XM_001929372.7 PREDICTED GGCGATTCTTCAGCAGGCTA GACCTGGTTCACCACTCTCG
FBLN7 XM_005662277.3 PREDICTED CCTCCGGATGGCAGAAAGTT TACCATTGGGAAGACACGCC

Quantitative RT-PCR analysis of select RNA sequencing targets

Total RNA was transcribed into cDNA using the Stratagene first-strand reverse transcription kit (Stratagene Cat#200420) according to the manufacturer. PCR primers were designed using Primer-BLAST [38] and qPCR amplification of template cDNA was performed in triplicate in a real-time thermocycler (Bio-Rad iCycler) using Sybr Green detection system (iQ SYBR® Green Supermix Bio Rad Cat#170–8880). qPCR targets were quantified using the "Fit Point Method" by iCycler Bio-Rad software (2 -ΔΔCT) and normalized to the expression levels of the housekeeping gene glyceraldehyde phosphate dehydrogenase (GAP) mRNA. Reaction specificity was ascertained by performing melt-curve analysis at the end of the amplification protocol, and the efficiency of the PCR reaction was evaluated from a dilution series of template (1:1, 1:5, 1:10, and 1:100) using the R2 value of the linear regression of Ct values for GAP, CCL8, and CCL2 (respective R2 values were 0.79, 0.94, and 0.76).

Supporting information

S1 Table

(PDF)

S2 Table

(PDF)

S1 Data

(XLSX)

Acknowledgments

The authors are grateful to Xinxin Shao for technical support.

Data Availability

The complete list of up- and down-regulated genes are available in Supplementary S1 and S2 Tables. Sequencing data are available on the NCBI Gene Expression Omnibus repository https://www.ncbi.nlm.nih.gov/geo/, (Accession no. GSE166656). The original data for PCR experiments, DAVID, PANTHER, and WGCNA analyses are available at the Open Science Framework (OSF) data repository (DOI: 10.17605/OSF.IO/75NUG).

Funding Statement

These studies were supported by a NIH grant 5R21AT4055-2 to authors GK and NAD. https://www.nih.gov/ Funders did not play a role in study design, data collection, decision to publish, or manuscript preparation.

References

  • 1.Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018. 9;391(10137):2356–67. 10.1016/S0140-6736(18)30480-X [DOI] [PubMed] [Google Scholar]
  • 2.GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017. September 16;390(10100):1211–59. 10.1016/S0140-6736(17)32154-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000. January;84(1):95–103. 10.1016/S0304-3959(99)00187-6 [DOI] [PubMed] [Google Scholar]
  • 4.de Campos TF. Low back pain and sciatica in over 16s: assessment and management NICE Guideline [NG59]. J Physiother. 2017. April;63(2):120. 10.1016/j.jphys.2017.02.012 [DOI] [PubMed] [Google Scholar]
  • 5.Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen M, et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60–75. 10.1007/s00586-017-5099-2 [DOI] [PubMed] [Google Scholar]
  • 6.Wong JJ, Côté P, Sutton DA, Randhawa K, Yu H, Varatharajan S, et al. Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain. 2017;21(2):201–16. 10.1002/ejp.931 [DOI] [PubMed] [Google Scholar]
  • 7.Kawchuk GN, Carrasco A, Beecher G, Goertzen D, Prasad N. Identification of spinal tissues loaded by manual therapy: a robot-based serial dissection technique applied in porcine motion segments. Spine. 2010. October 15;35(22):1983–90. 10.1097/BRS.0b013e3181ddd0a3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Crean JK, Roberts S, Jaffray DC, Eisenstein SM, Duance VC. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine. 1997. December 15;22(24):2877–84. 10.1097/00007632-199712150-00010 [DOI] [PubMed] [Google Scholar]
  • 9.Stokes IAF, Aronsson DD, Clark KC, Roemhildt ML. Intervertebral disc adaptation to wedging deformation. Stud Health Technol Inform. 2006;123:182–7. [PubMed] [Google Scholar]
  • 10.Walsh AJL, Lotz JC. Biological response of the intervertebral disc to dynamic loading. J Biomech. 2004. March;37(3):329–37. 10.1016/s0021-9290(03)00290-2 [DOI] [PubMed] [Google Scholar]
  • 11.Wuertz K, Godburn K, MacLean JJ, Barbir A, Donnelly JS, Roughley PJ, et al. In vivo remodeling of intervertebral discs in response to short- and long-term dynamic compression. J Orthop Res. 2009. September;27(9):1235–42. 10.1002/jor.20867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Iatridis JC, Godburn K, Wuertz K, Alini M, Roughley PJ. Region-dependent aggrecan degradation patterns in the rat intervertebral disc are affected by mechanical loading in vivo. Spine. 2011. February 1;36(3):203–9. 10.1097/BRS.0b013e3181cec247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Parolin M, Gawri R, Mwale F, Steffen T, Roughley P, Antoniou J, et al. Development of a whole disc organ culture system to study human intervertebral disc. Evid Based Spine Care J. 2010. August;1(2):67–8. 10.1055/s-0028-1100919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hartman RA, Bell KM, Debski RE, Kang JD, Sowa GA. Novel ex-vivo mechanobiological intervertebral disc culture system. J Biomech. 2012. January 10;45(2):382–5. 10.1016/j.jbiomech.2011.10.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Grant M, Epure LM, Salem O, AlGarni N, Ciobanu O, Alaqeel M, et al. Development of a Large Animal Long-Term Intervertebral Disc Organ Culture Model That Includes the Bony Vertebrae for Ex Vivo Studies. Tissue Eng Part C Methods. 2016;22(7):636–43. 10.1089/ten.TEC.2016.0049 [DOI] [PubMed] [Google Scholar]
  • 16.Hutton W. C. et al. Do the intervertebral disc cells respond to different levels of hydrostatic pressure? Clin Biomech (Bristol, Avon) 16, 728–734 (2001). 10.1016/s0268-0033(01)00080-8 [DOI] [PubMed] [Google Scholar]
  • 17.Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther. 2009. October;14(5):531–8. 10.1016/j.math.2008.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bogduk N. The innervation of the lumbar spine. Spine. 1983. April;8(3):286–93. 10.1097/00007632-198304000-00009 [DOI] [PubMed] [Google Scholar]
  • 19.Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. J Bone Joint Surg Br. 2005. January;87(1):62–7. [PubMed] [Google Scholar]
  • 20.MacLean JJ, Roughley PJ, Monsey RD, Alini M, Iatridis JC. In vivo intervertebral disc remodeling: kinetics of mRNA expression in response to a single loading event. J Orthop Res. 2008. May;26(5):579–88. 10.1002/jor.20560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wong AYL, Parent EC, Dhillon SS, Prasad N, Kawchuk GN. Do participants with low back pain who respond to spinal manipulative therapy differ biomechanically from nonresponders, untreated controls or asymptomatic controls? Spine. 2015. September 1;40(17):1329–37. 10.1097/BRS.0000000000000981 [DOI] [PubMed] [Google Scholar]
  • 22.Koerner JD, Markova DZ, Yadla S, Mendelis J, Hilibrand A, Vaccaro AR, et al. Differential gene expression in anterior and posterior annulus fibrosus. Spine. 2014. November 1;39(23):1917–23. 10.1097/BRS.0000000000000590 [DOI] [PubMed] [Google Scholar]
  • 23.O’Connell GD, Vresilovic EJ, Elliott DM. Human intervertebral disc internal strain in compression: the effect of disc region, loading position, and degeneration. J Orthop Res. 2011. April;29(4):547–55. 10.1002/jor.21232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bruehlmann SB, Rattner JB, Matyas JR, Duncan NA. Regional variations in the cellular matrix of the annulus fibrosus of the intervertebral disc. J Anat. 2002. August;201(2):159–71. 10.1046/j.1469-7580.2002.00080.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Marchuk L, Sciore P, Reno C, Frank CB, Hart DA. Postmortem stability of total RNA isolated from rabbit ligament, tendon and cartilage. Biochim Biophys Acta. 1998. February 2;1379(2):171–7. 10.1016/s0304-4165(97)00094-9 [DOI] [PubMed] [Google Scholar]
  • 26.Jansen KA, Donato DM, Balcioglu HE, Schmidt T, Danen EHJ, Koenderink GH. A guide to mechanobiology: Where biology and physics meet. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research [Internet]. 2015. November 1 [cited 2018 Sep 5];1853(11, Part B):3043–52. Available from: http://www.sciencedirect.com/science/article/pii/S0167488915001536 [DOI] [PubMed] [Google Scholar]
  • 27.Travascio F, Elmasry S, Asfour S. Modeling the role of IGF-1 on extracellular matrix biosynthesis and cellularity in intervertebral disc. J Biomech. 2014. July 18;47(10):2269–76. 10.1016/j.jbiomech.2014.04.046 [DOI] [PubMed] [Google Scholar]
  • 28.Wiesenfeld-Hallin Z, Xu X-J, Crawley JN, Hökfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides. 2005. June;39(3):207–10. 10.1016/j.npep.2004.12.017 [DOI] [PubMed] [Google Scholar]
  • 29.Barczewska M, Juranek J, Wojtkiewicz J. Origins and Neurochemical Characteristics of Porcine Intervertebral Disc Sympathetic Innervation: a Preliminary Report. J Mol Neurosci. 2017;63(1):50–7. 10.1007/s12031-017-0956-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Botz B, Kemény Á, Brunner SM, Locker F, Csepregi J, Mócsai A, et al. Lack of Galanin 3 Receptor Aggravates Murine Autoimmune Arthritis. J Mol Neurosci. 2016. June;59(2):260–9. 10.1007/s12031-016-0732-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kawchuk GN, Perle SM. The relation between the application angle of spinal manipulative therapy (SMT) and resultant vertebral accelerations in an in situ porcine model. Man Ther. 2009. October;14(5):480–3. 10.1016/j.math.2008.11.001 [DOI] [PubMed] [Google Scholar]
  • 32.Herzog W, Conway PJ, Kawchuk GN, Zhang Y, Hasler EM. Forces exerted during spinal manipulative therapy. Spine. 1993. July;18(9):1206–12. 10.1097/00007632-199307000-00014 [DOI] [PubMed] [Google Scholar]
  • 33.Reno C, Marchuk L, Sciore P, Frank CB, Hart DA. Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. BioTechniques. 1997. June;22(6):1082–6. 10.2144/97226bm16 [DOI] [PubMed] [Google Scholar]
  • 34.Ward JH. Hierarchical Grouping to Optimize an Objective Function. Journal of the American Statistical Association [Internet]. 2012. April 10 [cited 2018 Dec 18]; https://amstat.tandfonline.com/doi/abs/10.1080/01621459.1963.10500845 [Google Scholar]
  • 35.Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. 10.1038/nprot.2008.211 [DOI] [PubMed] [Google Scholar]
  • 36.Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17. 10.2202/1544-6115.1128 [DOI] [PubMed] [Google Scholar]
  • 37.R Core Team (2018). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/. [Google Scholar]
  • 38.Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012. June 18;13:134 10.1186/1471-2105-13-134 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Rajakumar Anbazhagan

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

19 Aug 2020

PONE-D-20-22566

Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi

PLOS ONE

Dear Dr. Matyas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The study is well planned and conducted. The data obtained are interesting, However there are few concern which should be addressed carefully on the specificity of AF using AF markers. In addition the authors has to specifically explain the choice of age groups, method of loading, Number of samples and number of repetitions carefully.  Further interaction of AF with other cells/ factors including from NP will add value owing to the importance of NP cells in IVD well being and regeneration etc. 

Please submit your revised manuscript by Oct 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Rajakumar Anbazhagan, Ph. D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).

3. Please upload a copy of Supplementary Tables S1 and S2 which you refer to in your text on page 6.

Additional Editor Comments (if provided):

The study is well planned and conducted. The data obtained are interesting, However there are few concerns which should be addressed carefully on the specificity of AF using AF markers. In addition the authors has to specifically explain the choice of age groups, method of loading, Number of samples and number of repetitions carefully. Further interaction of AF with other cells/ factors including from NP is very important owing to the importance of NP cells in Bio-mechanical/osmolarity, IVD well being and regeneration etc. Improving the Heat map and adding pathway interaction analysis will add value to the study.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Partly

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Matyas et al., describes the effect of repetitive manual loading applied to the lumbar spine on genes expression in annuli fibrosi cells, to determine whether manual therapy has a positive effect on spine. I think that the manuscript is well written and the idea behind the manuscript is good but I have some major concerns regarding this study.

They used 10 animals (6 Non-loaded and 4 Hyperloaded) but then they decided to use 6 controls and 6 hyperloaded sample for the RNA sequencing analysis as the claim in the methods “The two extra Hyperloaded sample replicates from annulus level L3-4 were powdered, isolated, and purified independently to assess repeatability”. Is not clear if this data were included in the analysis at the end.

Moreover they did not assess the health status of the discs in the animals. Why they did not use also degenerated discs or older animals? I think that if the idea is to understand the effect of manual therapy on spine the assumption should be that individuals that are recommended for therapy have back pain and most probably degenerated discs.

Why they analyze the gene expression changes only in annuli fibrosis and did not analyze also nucleus pulposus cells? It is know that NP cells are important for formation and maintenance of IVD and they are considered signaling center in the IVD (Richardson SM et al., 2017; Hiyama et al., 2013; Winkler T et al., 2014), so would have been a more informative study including also information coming from NP cells. They also did not check the purity of preparation (contamination in AF cells from NP or end plate).

Even though the data presented here are indicative of an effect of manual therapy on spine health, additional experiments and data would be needed to support their hypothesis.

Reviewer #2: The manuscript entitled “Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosis” by Matyas et al., analyzed the response of annuli fibrosis for in vivo loading using a transcriptomic approach. The study is interesting and uncovered the differential expression of genes involved in the metabolic process. Although there are certain limitations (due to model and variable response of IVD to loading and corresponding cellular response) in the study which the authors fairly pointed in the discussion studies of similar kind in future will lay the foundation to understand the molecular and biochemical response to physical forces in treating back pain. As the authors rightly concluded there is a need for additional studies in the field to confirm the observed transcriptome regulation to interpret the results clinically.

Overall the manuscript is well written, easy to understand, and adequately detailed for the methods followed. I recommend accepting this manuscript with a minor revision.

Minor suggestions.

1. At the outset how do the authors rule out the observed changes in mRNA regulations are not due to stress applied during the hyper loading procedure?

2. Since the current study can stand as a reference to future studies on IVD loading Is it possible for the authors to group or cluster the differentially regulated genes and show how the regulated genes interact (using tools like DAVID for interaction analysis) with genes differentially regulated in IVD degenerative disease data sets? This will support to claim that the genes regulated after the short term repetitive IVD loading procedure could compensate for the clinical need.

3. The authors can move Figure 1A to supplement and keep Figure 1B as main Figure 1.

4. The authors can represent the qPCR data as a bar graph in Figure 2 along with the RNA seq fold change. Label the genes in the RNA seq Fold change panel. This data can also be combined as panel B and C in Figure 1.

5. I believe Fig 3 is a representation of Table 4, If not what is the difference in the analysis?

6. From the GO analysis, I see the upregulation of genes involved in immune response which is not very well discussed in the manuscript. The upregulated immune genes or pathways could be key for the therapy? please discuss.

7. Also, the pictorial representation of gene ontology in Fig 3 should be verified for the functional terms on Y-axis.

8. The authors cited Table S1 and S2 for differentially regulated genes, but I could not find the supplement file in the submission.

9. Please provide the GEO accession for the data set submission

10. Dataset submitted to OSF needs to be curated carefully for missing gene name and details

Reviewer #3: The Manuscript entitled “Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi” describes the transcriptomic analysis of ventral annuli fibrosi to single dose of spine manual loading. They use a total of 10 replicates to drive the expression of annuli fibrosi cells. The analysis presented in this paper explains, in brief, the functional roles of transcripts after manual loading. In-depth data analysis, such as pathway analysis would have added more value to the paper. Some issues need to be addressed to improve the manuscript overall,

1. The discussion is quite vague and not comprehensive. A major portion of the discussions are on the limitation of the study. A more detailed description of the biological importance of the differentially expressed genes is required.

2. Can the authors explain in brief the functional role of the Annuli fibrosi cells, why these cells were chosen for the study?

3. How many females and males were used? why 3-4 months old were chosen? How relevant it is to use 3-4 months old pig for this study?

4. ketamine, acepromazine, xlyazine, azaperone, and glycopyrrolate? Were all the drugs combined to anesthetize the pigs? What is the dosage used?

5. To identify all majority of DEGs, at least six biological replicates per condition of experiments is recommended. I was wondering why there is a discrepancy in the number of replicates between control and hyperloaded? The hyperloaded pigs are treated differently and have two subgroups. Did the authors make sure that there are no treatment effects within the subgroups of hyper loaded animals? A PCA plot in this case would be useful. I would suggest including PCA plots to see the differences between the groups.

6. No pathological conditions were induced in the pigs before spinal therapy. Apparently healthy pigs were given spinal therapy and gene expressions were compared. The cellular response to spinal therapy in a pathophysiological condition and a healthy individual may vary. The basis of spinal therapy is to relieve pain and molecular changes seen after spinal therapy may shed light on the molecular mechanism of such therapy. Can the author substantiate the reason to perform in healthy animals?

7. A little more careful explanation of the objective, rationale, and the discussion of the study is justified. The overall objective is not clear. The hyperloading was performed to compare the negative effects of spinal manual therapy or to compare the biological changes to spinal manual therapy in diseased state?

8. I would suggest the authors to perform a pathway crosstalk analysis to further characterize the significantly enriched genes-pathways and also to do a co-expression network analysis to see the interaction signature among the significantly DEG.

9. The heat map is of very poor quality. A brief explanation below each figure would be helpful.

Reviewer #4: The manuscript is about repetitive in vivo manual loads on porcine intervertebral disc using RNA –seq data. This is a very simple but neatly done preliminary study that can be accepted with minor revision.

1. Did authors try to look into in the MRI of the spine of control and hyperloadede animals ? Will they expect any changes ?

2. How many times manual loading was performed ? Can authors explain the significance of timeline of manual loading to sample collection. Where the animals allowed to rest post manual loading ?

3. Did the authors look into aged pigs where the disc degeneration is natural.

4. Figure 1 can be explained in detail in the legends and Figure 2 name the genes analyzed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: reviwer comment.docx

Decision Letter 1

Rajakumar Anbazhagan

5 Feb 2021

PONE-D-20-22566R1

Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi

PLOS ONE

Dear Dr. Matyas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Authors should address all comments of all Reviewers. The current revision has "only answers to Reviewer 3"

Please submit your revised manuscript by Mar 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Author should address all comments of all Reviewers. The current revision has answers to only Reviewer 3.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Rajakumar Anbazhagan

22 Feb 2021

Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi

PONE-D-20-22566R2

Dear Dr. Matyas,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rajakumar Anbazhagan, Ph. D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #6: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #6: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #6: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #6: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #6: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #6: The authors have addressed my queries and edited the manuscript considering my suggestions. I accept the manuscript in its current format.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #6: No

Acceptance letter

Rajakumar Anbazhagan

1 Mar 2021

PONE-D-20-22566R2

Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi

Dear Dr. Matyas:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rajakumar Anbazhagan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table

    (PDF)

    S2 Table

    (PDF)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: reviwer comment.docx

    Attachment

    Submitted filename: reviewer comment PLoS1_JRM responses v3.docx

    Attachment

    Submitted filename: reviewer comment PLoS1_JRM responses v3.docx

    Data Availability Statement

    The complete list of up- and down-regulated genes are available in Supplementary S1 and S2 Tables. Sequencing data are available on the NCBI Gene Expression Omnibus repository https://www.ncbi.nlm.nih.gov/geo/, (Accession no. GSE166656). The original data for PCR experiments, DAVID, PANTHER, and WGCNA analyses are available at the Open Science Framework (OSF) data repository (DOI: 10.17605/OSF.IO/75NUG).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES